REYNOLDS CAMERON JOHN (President and CEO) received a stock award from VOLITIONRX LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/6/2022ACC: 0001477932-22-007487
DirectorOfficer· President and CEO
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
16.7%
—
1.20M→1.40M
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | A · Award | +200K | — | — | 16.7% | 1.20M | 1.40M |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned34.08K
Total
1.04M indirect1.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 34.08K | Indirect |
| Total | 1.04M | 1.04M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported